Cite
HARVARD Citation
De Ruysscher, D. et al. (n.d.). EP-1366: Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC. Radiotherapy and oncology. pp. S745-S746. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
De Ruysscher, D. et al. (n.d.). EP-1366: Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC. Radiotherapy and oncology. pp. S745-S746. [Online].